Mirae Asset Global Investments Co., Ltd. Guardant Health, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,786 shares of GH stock, worth $322,911. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,786
Previous 4,130
15.88%
Holding current value
$322,911
Previous $175,000
42.29%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding GH
# of Institutions
417Shares Held
126MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$821 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$758 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$336 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$325 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$287 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $6.9B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...